Inmune Bio Share Price (NASDAQ: INMB)
$2.04
Last updated on
Check the interactive Inmune Bio Stock chart to analyse performance
Inmune Bio stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$2.03Today's High:$2.07
0.49%
Downside
Day's Volatility :1.93%
Upside
1.45%
- 52 Weeks Low:$1.8952 Weeks High:$11.64
7.35%
Downside
52 Weeks Volatility :83.76%
Upside
82.47%
Inmune Bio Stock Returns
Inmune Bio Inc Key Stats
Check Inmune Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Inmune Bio Stock including INR - Dollar returns
The Inmune Bio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Inmune Bio investment value today
Current value as on today
₹38,455
Returns
Returns from Inmune Bio Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Inmune Bio Stock
Global Institutional Holdings in Inmune Bio Inc
Name
Holdings %
BlackRock Inc
3.57%
Praetorian PR LLC
3.25%
Vanguard Group Inc
3.19%
Geode Capital Management, LLC
1.37%
Millennium Management LLC
0.91%
State Street Corp
0.89%
Analyst Recommendation on Inmune Bio Stock
Buy
88%Buy
11%Hold
0%Sell
Based on 9 Wall street analysts offering stock ratings for Inmune Bio(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Inmune Bio Share Price Target
What analysts predicted
Upside of 157.35%
Target:
$5.25
Current:
$2.04
Inmune Bio share price target is $5.25, a slight Upside of 157.35% compared to current price of $2.04 as per analysts' prediction.
Inmune Bio Stock Insights
Price Movement
In the last 7 days, INMB stock has moved down by -15.6%Increasing Revenue
Revenue is up for the last 2 quarters, 14.0K → 50.0K (in $), with an average increase of 72.0% per quarterDecreasing Net Profit
Netprofit is down for the last 3 quarters, -9.21M → -24.45M (in $), with an average decrease of 78.4% per quarterINMB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 139.2%INMB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 190.8%Price to Sales
ForINMB every $1 of sales, investors are willing to pay $1017.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Inmune Bio Technicals Summary
Sell
Neutral
Buy
Inmune Bio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Inmune Bio Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -20.51% | -73.71% | -66.91% | -74.97% | -91.14% |
 | 3.92% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 2.49% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -15.42% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 11.08% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.44 | -1.68 | -0.55 | NA | 1.09 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $55.6M | -91.14% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Inmune Bio Inc
Key Management of Inmune Bio Inc
Important FAQs about investing in INMB Stock from India :
What is Inmune Bio share price today?
Inmune Bio share price today is $2.04 as on at the close of the market. Inmune Bio share today touched a day high of $2.07 and a low of $2.03.
What is the 52 week high and 52 week low for Inmune Bio share?
Inmune Bio share touched a 52 week high of $11.64 and a 52 week low of $1.89. Inmune Bio stock price today i.e. is closed at $2.04, lower by 82.47% versus the 52 week high.
How to invest in Inmune Bio Stock (INMB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Inmune Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmune Bio Shares that will get you 0.7353 shares as per Inmune Bio share price of $2.04 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Inmune Bio Stock (INMB) from India?
Indian investors can start investing in Inmune Bio (INMB) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inmune Bio stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Inmune Bio share’s latest price of $2.04 as on August 30, 2025 at 1:29 am IST, you will get 4.9020 shares of Inmune Bio. Learn more about
fractional shares .
What are the returns that Inmune Bio has given to Indian investors in the last 5 years?
Inmune Bio stock has given -91.14% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%